fda semaglutide update Approves Oral Semaglutide: First GLP-1 Weight Loss Pill As of February 21, 2025,

Variable action: Dose, site, and activity can shift your curve

Aug 2019;32(4):581-587

That sustained rise can cause swelling and fluid retention, and has been linked to hormonal imbalances, disruption to ovarian function and a higher risk of miscarriage

The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action

These reductions in fat mass, lean body mass, and muscle mass correlate with the degree of body weight reduction and are similar to those documented with other obesity therapies that achieve large weight reductions, such as bariatric surgery and very low-calorie restricted diets [61]